Helical Tomotherapy for thymic tumor patients with pleural dissemination

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400086861

Enrollment

Unknown

Registered

2024-07-12

Start date

2024-07-15

Completion date

Unknown

Last updated

2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thymic tumor

Interventions

control group:Helical Tomotherapy, with BED 30-50Gy

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) pathologically diagnosed as thymic epithelial tumor (2) pleural dissemination is proven by CT imaging (3) age =18; (4) Karnofsky performance status, (KPS)=70

Exclusion criteria

Exclusion criteria: (1) active pulmonary inflammation (2) massive pleural effusion (3) with myasthenia gravis beyond Osserman 2 ,. (4) previous radiotherapy to thorax, and accumulated dose to ips-lateral lung V20>70%, or to total lung V20>30%. (5) pregnant or planning to become pregnant

Design outcomes

Secondary

Measure	Time frame
local cntrol time;overall survival time;	—

Primary

Measure	Time frame
Objective Response Rate;	—

Countries

China

Contacts

Public ContactYao Hui

Shanghai International Medical Center

yaohuish@126.com+86 133 7192 5336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026